0001493152-21-009294.txt : 20210420 0001493152-21-009294.hdr.sgml : 20210420 20210420213517 ACCESSION NUMBER: 0001493152-21-009294 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210416 FILED AS OF DATE: 20210420 DATE AS OF CHANGE: 20210420 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silverman Joshua CENTRAL INDEX KEY: 0001524858 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36268 FILM NUMBER: 21839295 MAIL ADDRESS: STREET 1: IROQUOIS CAPITAL MANAGEMENT LLC STREET 2: 205 EAST 42ND ST - 20TH FL. CITY: NEW YORK STATE: NY ZIP: 10017 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MyMD Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001321834 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 BUSINESS PHONE: 856-848-8698 MAIL ADDRESS: STREET 1: 1185 AVENUE OF THE AMERICAS STREET 2: 3RD FLOOR CITY: NEW YORK STATE: NY ZIP: 10036 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences, Inc. DATE OF NAME CHANGE: 20170413 FORMER COMPANY: FORMER CONFORMED NAME: Akers Biosciences Inc DATE OF NAME CHANGE: 20050325 4 1 ownership.xml X0306 4 2021-04-16 0 0001321834 MyMD Pharmaceuticals, Inc. MYMD 0001524858 Silverman Joshua 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK, NY 10036 1 0 0 0 Common Stock 2021-04-16 4 M 0 109500 A 112101 D Common Stock 2021-04-16 4 F 0 38325 4.94 D 71175 D Restricted Stock Units 2021-04-16 4 M 0 109500 0.00 D Common Stock 109500 0 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of MyMD Pharmaceuticals, Inc. (the "Company"). Represents 38,325 shares of RSUs withheld to pay the reporting person's tax withholding obligations incurred in connection with the vesting of 109,500 shares of RSUs on April 16, 2021. On September 11, 2020, the reporting person was granted 109,500 RSUs of the Company, which vested on April 16, 2021, upon the occurrence of a change in control. /s/ Joshua Silverman 2021-04-20